Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan

Abstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. Th...

Full description

Bibliographic Details
Main Authors: Chi Chen, Hei-Tung Yip, Kam-Hang Leong, Wei-Cheng Yao, Chung-Lieh Hung, Ching-Huang Su, Chien-Feng Kuo, Shin-Yi Tsai
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-03886-1
_version_ 1811165761835630592
author Chi Chen
Hei-Tung Yip
Kam-Hang Leong
Wei-Cheng Yao
Chung-Lieh Hung
Ching-Huang Su
Chien-Feng Kuo
Shin-Yi Tsai
author_facet Chi Chen
Hei-Tung Yip
Kam-Hang Leong
Wei-Cheng Yao
Chung-Lieh Hung
Ching-Huang Su
Chien-Feng Kuo
Shin-Yi Tsai
author_sort Chi Chen
collection DOAJ
description Abstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. This study aimed to clarify the preexisting comorbidities and treatments associated with patients with subsequent CFS diagnosis in a population-based cohort in Taiwan. Methods An analysis utilizing the National Health Insurance Research Database of Taiwan was conducted. Participants included were 6303 patients with CFS newly diagnosed between 2000 and 2010 and 6303 age-/sex-matched controls. Results Compared with the control group, the CFS group had a higher prevalence of depression and anxiety disorder before the diagnosis of CFS. Sampled patients who took specific types of antidepressants, namely, selective serotonin reuptake inhibitors (adjusted odds ratio [aOR] = 1.21, 95% confidence interval [CI] 1.04–1.39), serotonin antagonists and reuptake inhibitors (SARI; aOR = 1.87, 95% CI 1.59–2.19), and tricyclic antidepressants (aOR = 1.46, 95% CI 1.09–1.95), had an increased risk of CFS. CFS risk was also higher among participants taking benzodiazepine, muscle relaxants, and analgesic drugs. A sub-group analysis revealed that SARI use was related to an increased risk of CFS in the depression, anxiety disorder, male, and female groups. In the depression and anxiety disorder groups, analgesic drug use was associated with an increased CFS risk. Nonpharmacological treatment administration differed between men and women. Conclusion This population-based retrospective cohort study revealed an increased risk of CFS among populations with preexisting depression and anxiety disorder, especially those taking SARI and analgesic drugs.
first_indexed 2024-04-10T15:41:51Z
format Article
id doaj.art-3b2b329a0a8249d3b173be580cd24ff7
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-10T15:41:51Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-3b2b329a0a8249d3b173be580cd24ff72023-02-12T12:20:55ZengBMCJournal of Translational Medicine1479-58762023-02-0121112310.1186/s12967-023-03886-1Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in TaiwanChi Chen0Hei-Tung Yip1Kam-Hang Leong2Wei-Cheng Yao3Chung-Lieh Hung4Ching-Huang Su5Chien-Feng Kuo6Shin-Yi Tsai7Department of Psychiatry, National Taiwan University HospitalManagement Office for Health Data, China Medical University HospitalDepartment of Medicine, MacKay Medical CollegeDepartment of Anesthesiology and Pain Medicine, Min-Sheng General HospitalInstitute of Biomedical Sciences, MacKay Medical CollegeDepartment of Laboratory Medicine, MacKay Memorial HospitalDepartment of Medicine, MacKay Medical CollegeDepartment of Medicine, MacKay Medical CollegeAbstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. This study aimed to clarify the preexisting comorbidities and treatments associated with patients with subsequent CFS diagnosis in a population-based cohort in Taiwan. Methods An analysis utilizing the National Health Insurance Research Database of Taiwan was conducted. Participants included were 6303 patients with CFS newly diagnosed between 2000 and 2010 and 6303 age-/sex-matched controls. Results Compared with the control group, the CFS group had a higher prevalence of depression and anxiety disorder before the diagnosis of CFS. Sampled patients who took specific types of antidepressants, namely, selective serotonin reuptake inhibitors (adjusted odds ratio [aOR] = 1.21, 95% confidence interval [CI] 1.04–1.39), serotonin antagonists and reuptake inhibitors (SARI; aOR = 1.87, 95% CI 1.59–2.19), and tricyclic antidepressants (aOR = 1.46, 95% CI 1.09–1.95), had an increased risk of CFS. CFS risk was also higher among participants taking benzodiazepine, muscle relaxants, and analgesic drugs. A sub-group analysis revealed that SARI use was related to an increased risk of CFS in the depression, anxiety disorder, male, and female groups. In the depression and anxiety disorder groups, analgesic drug use was associated with an increased CFS risk. Nonpharmacological treatment administration differed between men and women. Conclusion This population-based retrospective cohort study revealed an increased risk of CFS among populations with preexisting depression and anxiety disorder, especially those taking SARI and analgesic drugs.https://doi.org/10.1186/s12967-023-03886-1Chronic fatigue syndromeDepressionAnxietyPharmacological treatment
spellingShingle Chi Chen
Hei-Tung Yip
Kam-Hang Leong
Wei-Cheng Yao
Chung-Lieh Hung
Ching-Huang Su
Chien-Feng Kuo
Shin-Yi Tsai
Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
Journal of Translational Medicine
Chronic fatigue syndrome
Depression
Anxiety
Pharmacological treatment
title Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
title_full Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
title_fullStr Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
title_full_unstemmed Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
title_short Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
title_sort presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome a population based study in taiwan
topic Chronic fatigue syndrome
Depression
Anxiety
Pharmacological treatment
url https://doi.org/10.1186/s12967-023-03886-1
work_keys_str_mv AT chichen presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT heitungyip presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT kamhangleong presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT weichengyao presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT chungliehhung presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT chinghuangsu presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT chienfengkuo presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan
AT shinyitsai presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan